Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.
| Autor: | Chun, Sang Hoon, Kim, Jung Hoon, Kwag, Seung-Jin, Kang, Myoung Hee, Park, Ji-Ho, Lee, Gyeong-Won, Kang, Jung Hun |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p157-157, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|